North America Active Pharmaceutical Ingredients Market
North America Active Pharmaceutical Ingredients Market Report by Drug Type (Innovative Active Pharmaceutical Ingredients, Generic Active Pharmaceutical Ingredients), Manufacturer Type (Captive Manufacturers, Merchant API Manufacturers), Synthesis Type (Synthetic Active Pharmaceutical Ingredients, Biotech Active Pharmaceutical Ingredients), Therapeutic Application (Oncology, Cardiovascular and Respiratory, Diabetes, Central Nervous System Disorders, Neurological Disorders, and Others), and Region 2024-2032
The North America active pharmaceutical ingredients market is expected to exhibit a growth rate (CAGR) of 5.8% during 2024-2032.
Market Growth Rate (2024-2032)
Active pharmaceutical ingredient (API) refers to the biologically/synthetic active component of a finished pharmaceutical product. Chemical synthesis, recombinant DNA, fermentation, isolation and recovery from natural sources are some of the common processes opted for API production. API in a drug is precisely used for curing, diagnosis, mitigation or prevention of human health issues. In addition to this, it has direct effect in restoring, correcting or modifying physiological functions of the body. On account of this, API has wide applications in the pharmaceuticals industry pertaining to oncology, central nervous system disorders, diabetes, neurological disorders, cardiovascular, respiratory disorders, etc.
The North American active pharmaceutical ingredients market is currently being driven by several factors. Predominantly, the rising geriatric population and escalated exposure to chronic diseases such as cancer and diabetes have escalated the API demand in the region. Apart from this, the US Government has increased the overall healthcare expenditure propelling the market growth. Pharmaceutical manufacturers have increased the investments in R&D for the development of better-quality APIs since it has a direct effect on the safety and efficacy of the drug. Moreover, technological advancements of new generation of APIs also represent an important factor driving the market growth in the region.
IMARC Group’s latest report provides a deep insight into the North America active pharmaceutical ingredients market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the North America active pharmaceutical ingredients market in any manner.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the North America active pharmaceutical ingredients market report, along with forecasts at the regional and country level from 2024-2032. Our report has categorized the market based on drug type, manufacturer type, synthesis type and therapeutic application.
Key Regions Analyzed
Analysis for Each Country
Market by Drug Type
Innovative Active Pharmaceutical Ingredients
Generic Active Pharmaceutical Ingredients
Market by Manufacturer Type
Merchant API Manufacturers
Innovative Merchant API Manufacturers
Generic Merchant API Manufacturers
Market by Synthesis Type
Synthetic Active Pharmaceutical Ingredients
Innovative Synthetic APIs
Generic Synthetic APIs
Biotech Active Pharmaceutical Ingredients
Market by Drug Type
Innovative Biotech APIs
Market by Product Type
Market by Expression System Type
Mammalian Expression System
Microbial Expression System
Yeast Expression System
Market by Therapeutic Application
Cardiovascular and Respiratory
Central Nervous System Disorders
Value Chain Analysis
Key Drivers and Challenges
Porters Five Forces Analysis
Key Player Profiles
Base Year of the Analysis
Drug Type, Manufacturer Type, Synthesis Type, Therapeutic Application, Country
United States, Canada, Mexico
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
Post-Sale Analyst Support
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
We expect the North America Active Pharmaceutical Ingredients (API) market to exhibit a CAGR of 5.8% during 2024-2032.
The rising prevalence of numerous chronic diseases, along with the growing number of clinical trials by various research centers and scientific laboratories, is primarily driving the North America Active Pharmaceutical Ingredients (API) market.
The sudden outbreak of the COVID-19 pandemic has led to the widespread adoption of Active Pharmaceutical Ingredients (API), owing to the increasing need for effective treatments and pharmaceutical drugs against the coronavirus infection across several North American nations.
Based on the drug type, the North America Active Pharmaceutical Ingredients (API) market has been divided into innovative active pharmaceutical ingredients and generic active pharmaceutical ingredients, where innovative active pharmaceutical ingredients currently exhibit a clear dominance in the market.
Based on the manufacturer type, the North America Active Pharmaceutical Ingredients (API) market can be categorized into captive manufacturers and merchant API manufacturers. Currently, captive manufacturers account for the majority of the North America market share.
Based on the synthesis type, the North America Active Pharmaceutical Ingredients (API) market has been segregated into synthetic active pharmaceutical ingredients and biotech active pharmaceutical ingredients, where synthetic active pharmaceutical ingredients currently hold the largest market share.
Based on the therapeutic application, the North America Active Pharmaceutical Ingredients (API) market can be bifurcated into oncology, cardiovascular and respiratory, diabetes, central nervous system disorders, neurological disorders, and others. Among these, oncology exhibits a clear dominance in the market.
On a regional level, the market has been classified into United States, Canada, and Mexico, where United States currently dominates the North America Active Pharmaceutical Ingredients (API) market.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.